Global, regional, and national burden of cardiovascular diseases attributable to metabolic risks across all age groups from 1990 to 2021: an analysis of the 2021 global burden of disease study data

Table 3 AAPC in ASMR for cardiovascular diseases attributable to metabolic risks (1990–2021)

	Global		High SDI		High-middle SDI		Middle SDI		Low-middle SDI		Low SDI
	Both	P	Both	P	Both	P	Both	P	Both	P	Both	P
Metabolic risks	− 1.28(− 1.42,− 1.14)	< 0.01	− 2.98(− 3.10,− 2.86)	< 0.01	− 1.51(− 1.78,− 1.23)	< 0.01	− 0.78(− 0.93,− 0.64)	< 0.01	− 0.16(− 0.39,0.07)	0.17	− 0.38(− 0.55,− 0.21)	< 0.01
High systolic blood pressure	− 1.33(− 1.49,− 1.17)	< 0.01	− 3.19(− 3.32,− 3.06)	< 0.01	− 1.53(− 1.79,− 1.26)	< 0.01	− 0.80(− 0.95,− 0.66)	< 0.01	− 0.15(− 0.39,0.09)	0.21	− 0.42(− 0.58,− 0.26)	< 0.01
High fasting plasma glucose	− 0.41(− 0.54,− 0.27)	< 0.01	− 1.90(− 1.98,− 1.83)	< 0.01	− 0.60(− 0.90,− 0.30)	< 0.01	0.10(− 0.08,0.29)	0.28	0.92(0.64,1.20)	< 0.01	0.56(0.35,0.77)	< 0.01
Kidney dysfunction	− 1.49(− 1.71,− 1.27)	< 0.01	− 3.32(− 3.39,− 3.25)	< 0.01	− 1.78(− 2.09,− 1.47)	< 0.01	− 0.88(− 1.06,− 0.70)	< 0.01	− 0.23(− 0.51,0.06)	0.12	− 0.38(− 0.61,− 0.15)	< 0.01
High LDL cholesterol	− 1.51(− 1.68,− 1.34)	< 0.01	− 3.53(− 3.67,− 3.39)	< 0.01	− 1.66(− 1.99,− 1.35)	< 0.01	− 0.41(− 0.57,− 0.24)	< 0.01	− 0.08(− 0.18,0.01)	0.11	− 0.16(− 0.35,0.02)	0.08
High body-mass index	− 0.21(− 0.37,− 0.05)	0.01	− 1.46(− 1.64,− 1.29)	< 0.01	− 0.48(− 0.85,− 0.11)	0.01	0.60(0.48,0.72)	< 0.01	1.17(1.11,1.24)	< 0.01	0.90(0.84,0.97)	< 0.01

ISSN: 1471-2458